Vertex Pharmaceuticals Stock Filter Stocks by Fundamentals

VRTX Stock  USD 418.01  0.69  0.17%   
Vertex Pharmaceuticals fundamentals help investors to digest information that contributes to Vertex Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Vertex Stock. The fundamental analysis module provides a way to measure Vertex Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vertex Pharmaceuticals stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vertex Number of Shares Shorted Analysis

Vertex Number of Shares Shorted Driver Correlations

Understanding the fundamental principles of building solid financial models for Vertex Pharmaceuticals is extremely important. It helps to project a fair market value of Vertex Stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Vertex Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vertex Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vertex Pharmaceuticals' interrelated accounts and indicators.
0.961.0-0.980.940.450.590.991.0-0.060.980.990.370.860.040.230.930.870.20.830.440.990.080.66-0.550.780.790.930.920.78
0.960.96-0.920.940.540.480.940.95-0.160.950.940.290.770.040.30.870.810.050.810.490.940.110.55-0.460.670.840.880.870.82
1.00.96-0.980.950.440.570.981.0-0.080.970.990.350.870.010.220.920.870.210.840.441.00.060.66-0.560.790.790.940.920.78
-0.98-0.92-0.98-0.94-0.38-0.54-0.96-0.990.06-0.95-0.99-0.34-0.840.0-0.13-0.89-0.89-0.24-0.84-0.45-0.990.02-0.660.55-0.79-0.68-0.96-0.97-0.69
0.940.940.95-0.940.470.290.890.94-0.120.930.930.070.79-0.140.120.790.810.10.760.580.94-0.070.44-0.350.630.810.90.890.79
0.450.540.44-0.380.470.130.460.430.270.470.430.10.33-0.20.210.230.390.120.350.530.4-0.170.050.110.220.570.370.330.54
0.590.480.57-0.540.290.130.660.580.070.550.590.880.590.410.370.750.540.380.57-0.170.580.360.88-0.80.760.30.510.480.32
0.990.940.98-0.960.890.460.660.990.010.980.980.470.830.120.270.940.870.190.810.430.970.170.68-0.550.780.780.910.90.76
1.00.951.0-0.990.940.430.580.99-0.060.980.990.370.850.030.210.930.890.210.830.441.00.070.65-0.560.780.760.940.940.75
-0.06-0.16-0.080.06-0.120.270.070.01-0.06-0.02-0.040.18-0.18-0.15-0.34-0.060.02-0.11-0.130.19-0.1-0.18-0.040.21-0.1-0.02-0.06-0.040.0
0.980.950.97-0.950.930.470.550.980.98-0.020.960.380.810.10.230.920.810.180.720.470.960.180.57-0.460.690.820.90.890.8
0.990.940.99-0.990.930.430.590.980.99-0.040.960.370.860.020.180.910.90.220.860.450.990.030.67-0.550.80.720.940.940.71
0.370.290.35-0.340.070.10.880.470.370.180.380.370.350.60.510.560.350.280.34-0.10.360.420.72-0.610.480.130.40.380.23
0.860.770.87-0.840.790.330.590.830.85-0.180.810.860.350.010.180.80.660.50.740.280.880.010.7-0.580.820.620.820.770.62
0.040.040.010.0-0.14-0.20.410.120.03-0.150.10.020.60.010.410.210.02-0.050.02-0.10.010.870.31-0.230.0-0.040.110.090.06
0.230.30.22-0.130.120.210.370.270.21-0.340.230.180.510.180.410.280.22-0.060.290.020.210.340.21-0.250.090.250.220.170.27
0.930.870.92-0.890.790.230.750.940.93-0.060.920.910.560.80.210.280.770.20.730.160.930.290.77-0.750.790.730.840.830.72
0.870.810.87-0.890.810.390.540.870.890.020.810.90.350.660.020.220.770.140.890.430.87-0.030.61-0.490.720.550.850.870.53
0.20.050.21-0.240.10.120.380.190.21-0.110.180.220.280.5-0.05-0.060.20.140.06-0.20.25-0.140.43-0.340.550.030.210.180.04
0.830.810.84-0.840.760.350.570.810.83-0.130.720.860.340.740.020.290.730.890.060.40.83-0.070.68-0.550.760.490.830.810.5
0.440.490.44-0.450.580.53-0.170.430.440.190.470.45-0.10.28-0.10.020.160.43-0.20.40.4-0.23-0.060.410.070.410.540.540.5
0.990.941.0-0.990.940.40.580.971.0-0.10.960.990.360.880.010.210.930.870.250.830.40.050.68-0.590.80.760.940.930.75
0.080.110.060.02-0.07-0.170.360.170.07-0.180.180.030.420.010.870.340.29-0.03-0.14-0.07-0.230.050.18-0.22-0.050.19-0.01-0.020.16
0.660.550.66-0.660.440.050.880.680.65-0.040.570.670.720.70.310.210.770.610.430.68-0.060.680.18-0.860.880.370.680.640.47
-0.55-0.46-0.560.55-0.350.11-0.8-0.55-0.560.21-0.46-0.55-0.61-0.58-0.23-0.25-0.75-0.49-0.34-0.550.41-0.59-0.22-0.86-0.73-0.28-0.52-0.5-0.3
0.780.670.79-0.790.630.220.760.780.78-0.10.690.80.480.820.00.090.790.720.550.760.070.8-0.050.88-0.730.480.730.70.49
0.790.840.79-0.680.810.570.30.780.76-0.020.820.720.130.62-0.040.250.730.550.030.490.410.760.190.37-0.280.480.650.590.95
0.930.880.94-0.960.90.370.510.910.94-0.060.90.940.40.820.110.220.840.850.210.830.540.94-0.010.68-0.520.730.650.990.73
0.920.870.92-0.970.890.330.480.90.94-0.040.890.940.380.770.090.170.830.870.180.810.540.93-0.020.64-0.50.70.590.990.66
0.780.820.78-0.690.790.540.320.760.750.00.80.710.230.620.060.270.720.530.040.50.50.750.160.47-0.30.490.950.730.66
Click cells to compare fundamentals
Competition

Based on the recorded statements, Vertex Pharmaceuticals has 0.0null of outstending shares currently sold short by investors. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Number of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Portfolio Anywhere Now

   

Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Vertex Pharmaceuticals ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Vertex Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Vertex Pharmaceuticals' managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Vertex Fundamentals

About Vertex Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vertex Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vertex Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vertex Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. Vertex Pharmaceutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 00 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock:
Check out Vertex Pharmaceuticals Piotroski F Score and Vertex Pharmaceuticals Altman Z Score analysis.
For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.181
Earnings Share
13.9
Revenue Per Share
38.297
Quarterly Revenue Growth
0.093
Return On Assets
0.1317
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.